Fermenta Biotech (FERMENTA) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
4.7B
Gross Profit
3.2B
68.60%
Operating Income
855.8M
18.23%
Net Income
764.0M
16.27%
Balance Sheet Metrics
Total Assets
6.1B
Total Liabilities
2.6B
Shareholders Equity
3.6B
Debt to Equity
0.71
Cash Flow Metrics
Operating Cash Flow
-59.5M
Free Cash Flow
187.7M
Revenue & Profitability Trend
Fermenta Biotech Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.7B | 3.3B | 3.5B | 4.0B | 3.7B |
| Cost of Goods Sold | 1.5B | 1.4B | 1.6B | 1.7B | 1.4B |
| Gross Profit | 3.2B | 1.9B | 1.9B | 2.3B | 2.3B |
| Operating Expenses | 1.5B | 891.9M | 916.8M | 973.2M | 822.0M |
| Operating Income | 855.8M | 94.1M | -10.2M | 391.7M | 668.1M |
| Pre-tax Income | 832.1M | -98.7M | -513.1M | 269.4M | 516.3M |
| Income Tax | 68.0M | 141.4M | 18.3M | 118.8M | 91.0M |
| Net Income | 764.0M | -240.1M | -531.3M | 150.6M | 425.3M |
| EPS (Diluted) | - | -₹7.99 | -₹17.70 | ₹5.33 | ₹15.69 |
Income Statement Trend
Fermenta Biotech Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 3.4B | 2.4B | 2.5B | 3.1B | 3.1B |
| Non-Current Assets | 2.8B | 3.1B | 3.8B | 3.9B | 3.8B |
| Total Assets | 6.1B | 5.5B | 6.4B | 7.1B | 6.9B |
| Liabilities | |||||
| Current Liabilities | 2.1B | 1.7B | 2.1B | 2.1B | 2.1B |
| Non-Current Liabilities | 440.8M | 894.1M | 1.2B | 1.3B | 1.2B |
| Total Liabilities | 2.6B | 2.6B | 3.2B | 3.4B | 3.3B |
| Equity | |||||
| Total Shareholders Equity | 3.6B | 2.9B | 3.1B | 3.7B | 3.6B |
Balance Sheet Composition
Fermenta Biotech Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 832.1M | -98.7M | -513.1M | 269.4M | 516.3M |
| Operating Cash Flow | -59.5M | 148.8M | 511.9M | 221.3M | 616.7M |
| Investing Activities | |||||
| Capital Expenditures | -28.8M | -191.4M | -404.4M | -370.4M | -552.6M |
| Investing Cash Flow | -28.8M | -191.4M | -404.4M | -370.4M | -485.4M |
| Financing Activities | |||||
| Dividends Paid | -36.1M | -36.1M | -42.0M | -72.1M | - |
| Financing Cash Flow | -394.5M | -728.5M | -195.6M | -35.4M | 177.4M |
| Free Cash Flow | 187.7M | 861.4M | 756.2M | 63.1M | 73.3M |
Cash Flow Trend
Fermenta Biotech Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.51
Price to Book
2.87
Price to Sales
2.21
Profitability Ratios
Profit Margin
16.37%
Operating Margin
22.22%
Return on Equity
23.74%
Return on Assets
9.20%
Financial Health
Current Ratio
1.58
Debt to Equity
32.06
Beta
-0.05
Per Share Data
EPS (TTM)
₹26.36
Book Value per Share
₹124.34
Revenue per Share
₹160.95
Financial data is updated regularly. All figures are in the company's reporting currency.